🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the manufacturers of Tylenol, alleging the firms hid potential risks that the pain reliever posed to pediatric neurological development.

The lawsuit comes thirty days after Former President Trump advocated an unverified association between consuming Tylenol - also known as paracetamol - during pregnancy and autism spectrum disorder in young ones.

Paxton is suing J&J, which previously sold the drug, the only pain reliever suggested for pregnant women, and the current manufacturer, which now manufacturers it.

In a statement, he claimed they "deceived the public by making money from suffering and promoting medication regardless of the dangers."

Kenvue states there is lacking scientific proof connecting acetaminophen to autism.

"These manufacturers deceived for years, deliberately risking numerous people to increase profits," Paxton, a Republican, declared.

The manufacturer stated officially that it was "deeply concerned by the perpetuation of misinformation on the security of acetaminophen and the likely effects that could have on the well-being of American women and children."

On its online platform, the company also said it had "regularly reviewed the relevant science and there is insufficient valid information that indicates a verified association between using paracetamol and autism spectrum disorder."

Associations representing doctors and medical practitioners agree.

The American College of Obstetricians and Gynecologists has stated paracetamol - the primary component in acetaminophen - is a restricted selection for pregnant women to manage discomfort and elevated temperature, which can pose significant medical dangers if left untreated.

"In over twenty years of studies on the utilization of paracetamol in gestation, no reliable research has conclusively proven that the consumption of paracetamol in any period of gestation results in neurodevelopmental disorders in young ones," the organization said.

The lawsuit references current declarations from the Trump administration in arguing the drug is potentially dangerous.

Last month, Trump generated worry from health experts when he instructed women during pregnancy to "resist strongly" not to consume acetaminophen when sick.

Federal regulators then issued a notice that doctors should contemplate reducing the usage of acetaminophen, while also mentioning that "a proven link" between the medication and autism spectrum disorder in minors has remains unverified.

The Health Department head Robert F Kennedy Jr, who oversees the Food and Drug Administration, had pledged in April to undertake "comprehensive study program" that would determine the source of autism in a matter of months.

But experts warned that finding a sole reason of autism spectrum disorder - thought by researchers to be the consequence of a intricate combination of inherited and environmental factors - would be difficult.

Autism is a form of enduring cognitive variation and condition that influences how persons perceive and engage with the environment, and is recognized using doctors' observations.

In his legal document, the attorney general - aligned with the former president who is seeking the Senate - asserts the manufacturer and J&J "deliberately disregarded and sought to suppress the evidence" around paracetamol and autism.

This legal action attempts to require the corporations "remove any promotional materials" that asserts acetaminophen is reliable for women during pregnancy.

This legal action echoes the complaints of a assembly of parents of minors with autism spectrum disorder and ADHD who took legal action against the makers of Tylenol in recently.

The court threw out the legal action, stating research from the parents' expert witnesses was inconclusive.